Innovating Works
HORIZON-EIC-2021-PATHFINDERCHA...
Tools to measure and stimulate activity in Brain Tissue
Sólo fondo perdido 0 €
Comunidad autónoma
Esta convocatoria está cerrada Esta línea ya está cerrada por lo que no puedes aplicar. Cerró el pasado día 27-10-2021.
Se espera una próxima convocatoria para esta ayuda, aún no está clara la fecha exacta de inicio de convocatoria.
Por suerte, hemos conseguido la lista de proyectos financiados!
Presentación: Consorcio Consorcio: Esta ayuda está diseñada para aplicar a ella en formato consorcio..
Esta ayuda financia Proyectos:

Scope:Medical devices to measure and stimulate brain activity are emerging as tremendously powerful therapeutic tools that could revolutionise the treatment of brain diseases. Anomalous neuronal electrical signals are present in a wide range of disorders including memory impairment (Alzheimer’s), epilepsy, chronic pain, mood disorders, movement disorders (Parkinson’s), ischemic cognitive decline (post-heart attack), sensory disorders (hearing loss, tinnitus), cerebrovascular events, aging related neurodegeneration, traumatic brain injury amongst many others.

Unfortunately, existing devices to restore normal patterns of brain activity by stimulation have serious limitations. Invasiveness, limited miniaturisation, poor resolution (with only coarse measurement and stimulation available), limited spatial coverage (not able to monitor or stimulate a sufficient number of neurons) hamper the therapeutic effect or render these solutions unattractive for clinicians and patients.

Yet today’s state-of-the art microelectronics and microfabrication are potentially conducive to novel neuro-devices with high levels of miniaturisation, ultra-low power consumption, multi-s... ver más

Scope:Medical devices to measure and stimulate brain activity are emerging as tremendously powerful therapeutic tools that could revolutionise the treatment of brain diseases. Anomalous neuronal electrical signals are present in a wide range of disorders including memory impairment (Alzheimer’s), epilepsy, chronic pain, mood disorders, movement disorders (Parkinson’s), ischemic cognitive decline (post-heart attack), sensory disorders (hearing loss, tinnitus), cerebrovascular events, aging related neurodegeneration, traumatic brain injury amongst many others.

Unfortunately, existing devices to restore normal patterns of brain activity by stimulation have serious limitations. Invasiveness, limited miniaturisation, poor resolution (with only coarse measurement and stimulation available), limited spatial coverage (not able to monitor or stimulate a sufficient number of neurons) hamper the therapeutic effect or render these solutions unattractive for clinicians and patients.

Yet today’s state-of-the art microelectronics and microfabrication are potentially conducive to novel neuro-devices with high levels of miniaturisation, ultra-low power consumption, multi-site sensor/stimulator arrays (linear, planar or 3D with a wealth of geometries) and wireless architectures, leading to lower risk, shorter recovery times and better patient acceptance.

Further, progress can also be achieved by the discovery of new physical principles for activity monitoring (invasive or non-invasive) and activity modulation. These could explore ultrasound, light (optogenetics or otherwise), mechanical stimulation, local release of neuroactive compounds, ionising radiation, etc.

It is the right time to explore these opportunities and develop novel neurodevices that can be rapidly accepted by clinicians and patients.

Proposals submitted to this call should tackle at least one of the following two challenges:

A full device with unique features, e.g. targeting a currently untreated disorder, offering unprecedented miniaturisation, low latency closed-loop monitoring-stimulation feedback (if necessary), ultra-low power consumption, low/moderate invasiveness (e.g. compatible with implantation with endoscopic techniques), high-resolution, sustainable, etc. or

New or nascent physical principles or methodologies that could be the basis for future brain sensing and/or stimulation technologies, with clear and quantifiable advantages. Focus is on techniques that can offer unprecedented data on brain function or that allow unprecedented modulation of brain activity for therapeutic purposes or brain-computer interfacing. Specific conditions for this challenge

Proposals targeting a full device are strongly encouraged to establish a plausible work plan to realise by the end of the project at least 1) a working prototype device or instrument and 2) pre-clinical data with proof of therapeutic action.

Proposals targeting the discovery of a new mechanism for monitor and/or stimulate are advised to de-risk the work plan by exploring multiple strategies in parallel, merging competing strategies into a single proposal for cost efficiencies and increased likelihood of success.

Consortia considering both targets in a single proposal are advised to carefully analyse whether the high risk inherent to the discovery of new mechanisms or principles could hamper the plausibility of completing a full device hinging on said principles.

All proposals must fully justify the clinical need for the targeted development, and structure the work plan accordingly, towards credible future transition to market. Proposals need to consider the cost-benefit of the targeted technology and demonstrate that the outcome will be acceptable by clinicians and patients.

The gender dimension in research content should be taken into account, where relevant.

For more details, see the EIC Work Programme 2021 and the relevant Challenge Guide.


ver menos

Temáticas Obligatorias del proyecto: Temática principal:

Características del consorcio

Ámbito Comunidad autónoma :
Solo pueden aplicar a esta linea las empresas con sede en:
Tipo y tamaño de organizaciones: El diseño de consorcio necesario para la tramitación de esta ayuda necesita de:
Empresas Micro, Pequeña, Mediana, Grande
Centros Tecnológicos
Universidades
Organismos públicos

Características del Proyecto

Requisitos de diseño: Duración: ¿Quieres ejemplos? Puedes consultar aquí los últimos proyectos conocidos financiados por esta línea, sus tecnologías, sus presupuestos y sus compañías.
Capítulos financiables: Los capítulos de gastos financiables para esta línea son:
Madurez tecnológica: La tramitación de esta ayuda requiere de un nivel tecnológico mínimo en el proyecto de TRL 4:. Es el primer paso para determinar si los componentes individuales funcionarán juntos como un sistema en un entorno de laboratorio. Es un sistema de baja fidelidad para demostrar la funcionalidad básica y se definen las predicciones de rendimiento asociadas en relación con el entorno operativo final. leer más.
TRL esperado:
Estadísticas proyectos financiados: Te facilitamos algunas estadísticas de los últimos 9 proyectos tramitados conocidos por categoría de empresa, porcentaje y presupuesto medio.

Categoria

%

Presupuesto medio

Micro

20%

0€

Mediana

40%

0€

Grande

40%

0€

Características de la financiación

Intensidad de la ayuda: Sólo fondo perdido + info
Fondo perdido:
0% 25% 50% 75% 100%
The funding rate of this grant will be 100% of the eligible costs.
Condiciones: No existe condiciones financieras para el beneficiario.

Información adicional de la convocatoria

Efecto incentivador: Esta ayuda no tiene efecto incentivador. + info.
Respuesta Organismo: Se calcula que aproximadamente, la respuesta del organismo una vez tramitada la ayuda es de:
Meses de respuesta:
Muy Competitiva:
No Competitiva Competitiva Muy Competitiva
No conocemos el presupuesto total de la línea pero en los últimos 6 meses la línea ha concecido
Total concedido en los últimos 6 meses.
Minimis: Esta línea de financiación NO considera una “ayuda de minimis”. Puedes consultar la normativa aquí.

Otras ventajas

Sello PYME: Tramitar esta ayuda con éxito permite conseguir el sello de calidad de “sello pyme innovadora”. Que permite ciertas ventajas fiscales.